Compositional Magnetic Resonance Imaging Measures of Cartilage — Endpoints for Clinical Trials of Disease-Modifying Osteoarthritis Drugs?

Journal of Rheumatology - Canada
doi 10.3899/jrheum.150663
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Journal of Rheumatology

Related search

OARSI Clinical Trials Recommendations: Hip Imaging in Clinical Trials in Osteoarthritis

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2015English

Association Between Disease-Specific Quality of Life and Magnetic Resonance Imaging Outcomes in a Clinical Trial of Prolotherapy for Knee Osteoarthritis

Archives of Physical Medicine and Rehabilitation
Physical TherapySports TherapyRehabilitationSports Science
2013English

Structural Changes of Hip Osteoarthritis Using Magnetic Resonance Imaging

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2014English

Magnetic Resonance Imaging in the Clinical Diagnosis of Creutzfeldt-Jakob Disease

Archives of Neurology
2000English

Magnetic Resonance Imaging for Diagnosis of Early Alzheimer's Disease

Revue Neurologique
Neurology
2013English

Longitudinal Magnetic Resonance Imaging in Progressive Supranuclear Palsy: A New Combined Score for Clinical Trials

Movement Disorders
Neurology
2017English

Exploring Novel Endpoints for Clinical Trials in Kidney Disease: Challenges and Opportunities

Kidney International Reports
Nephrology
2017English

Clinical Applications of Cardiovascular Magnetic Resonance Imaging

CMAJ
Medicine
2006English

OARSI–OMERACT Initiative: Defining Thresholds for Symptomatic Severity and Structural Changes in Disease Modifying Osteoarthritis Drug (DMOAD) Clinical Trials

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy